Caribou Biosciences
CRBU
126 hedge funds and large institutions have $338M invested in Caribou Biosciences in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 19 reducing their positions, and 20 closing their positions.
205% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 19
82% more capital invested
Capital invested by funds: $185M → $338M (+$153M)
69% more call options, than puts
Call options by funds: $616K | Put options by funds: $364K
40% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 20
8.87% more ownership
Funds ownership: 71.3% → 80.17% (+8.9%)
5% more funds holding
Funds holding: 120 → 126 (+6)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$26.6M |
| 2 |
DM
Deerfield Management
New York
|
+$21.7M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$20.4M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.9M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.64M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.76M |
| 3 |
MSKCC
Memorial Sloan Kettering Cancer Center
New York
|
-$2.31M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.85M |
| 5 |
Jane Street
New York
|
-$771K |
CRBU Hedge Fund Activity: Q3 2023 in Review
126 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q3 2023, worth a combined $338M — up 82% from $185M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new CRBU positions and 20 closed out — a net gain of 8 holders — while 58 added to existing stakes and 19 trimmed.
The largest buyer was State Street, adding an estimated $26.6M. The largest seller was Millennium Management, cutting an estimated $3.64M.
- 126 institutional investors held Caribou Biosciences (CRBU) as of Q3 2023, up from 120 in Q2 2023.
- Funds reported $338M of Caribou Biosciences stock for Q3 2023, up 82% quarter-over-quarter.
- 28 funds opened new Caribou Biosciences positions in Q3 2023 and 20 closed out, a net change of +8 holders.
- The largest Caribou Biosciences buyer in Q3 2023 was State Street, an estimated $26.6M added.
- The largest Caribou Biosciences seller in Q3 2023 was Millennium Management, an estimated $3.64M sold.
Based on aggregated 13F filings for Q3 2023.